Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC) [Phase 4]
Phase 4 clinical trial evaluating HCV-RNA kinetics in patients with hepatocellular carcinoma treated with sorafenib; the study was terminate…
-
CLINICAL_TRIALS research · 2017-03-13Clinical Trial Update: The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer
This clinical trial update discusses the potential roles of ctDNA, PVT1, and reactive oxygen species in diagnosing and treating gastrointest…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer [Phase 2]
Phase 2 trial evaluating oxaliplatin and capecitabine for unresectable metastatic hepatocellular carcinoma was terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer [Phase 2]
Phase 2 trial evaluating individualized stereotactic body radiotherapy for intrahepatic cancers has completed and results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma [Phase 2]
This Phase 2 trial evaluated neoadjuvant sorafenib therapy prior to laser ablation for hepatocellular carcinoma. The study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma [Phase 1]
This clinical trial update reports results from a Phase I/Ib study of AZD9150 (ISIS-STAT3Rx) in patients with advanced or metastatic hepatoc…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Study of ARQ 197 in Hepatocellular Carcinoma (HCC) [Phase 1]
A Phase 1 trial of ARQ 197 for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Clemizole HCl for Subjects With Hepatocellular Carcinoma [Phase 2]
This document provides a Phase 2 clinical trial update for Clemizole hydrochloride in hepatocellular carcinoma, with the current status not …
-
CLINICAL_TRIALS research · 2017-02-28Clinical Trial Update: Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma [NA]
This entry reports a clinical trial evaluating the combination of transarterial chemoembolization (TACE) with apatinib for hepatocellular ca…
-
CLINICAL_TRIALS research · 2017-02-24Clinical Trial Update: Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications [NA]
Clinical trial update describing hepatic arteriography for diagnosis and staging of hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2017-02-23Clinical Trial Update: Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients [Phase 2]
Phase 2 trial comparing transcatheter arterial chemoembolization (TACE) with arsenic trioxide versus TACE alone for primary hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma [Phase 1]
Phase 1 trial results evaluating stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma have been r…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
A City of Hope Medical Center trial evaluating Yttrium-90 radiolabeled glass beads for unresectable liver cancer is no longer available.
-
CLINICAL_TRIALS research · 2017-02-14Clinical Trial Update: Prospective Post Y90 Liver Hypertrophy
A clinical trial update on prospective post-Yttrium-90 therapy aimed at liver hypertrophy in hepatocellular carcinoma patients; current stat…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B [Phase 2]
A Phase 2 trial evaluating hepatic arterial infusion chemotherapy (HAIC) versus transarterial chemoembolization (TACE) for large unresectabl…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 trial evaluating axitinib as second-line therapy for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating lenalidomide as second-line therapy for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC) [Phase 2]
Phase 2 clinical trial of apatinib for advanced hepatocellular carcinoma; the update does not provide results and lists the status as UNKNOW…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma [Phase 2]
Patupilone was studied in a Phase 2 trial for advanced/metastatic hepatocellular carcinoma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence [Phase 2]
Phase 2 trial assessing whether oral thalidomide plus tegafur-uracil can decrease recurrence of hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Added Value of Gadoxetic Acid-enhanced Liver MRI
A completed clinical trial evaluating the added diagnostic value of gadoxetic acid-enhanced liver MRI for hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: RAD001 in Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial of RAD001 (everolimus) in advanced hepatocellular carcinoma has completed enrollment. Results were posted in 2017.
-
CLINICAL_TRIALS other · 2017-02-06Clinical Trial Update: Optimization of Health Expenditure in Liver Surgery
Update on a liver-surgery clinical trial focused on optimizing health expenditure, involving hepatocellular carcinoma, hilar cholangiocarcin…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer [Phase 2]
This Phase 2 trial update reports the termination of a study evaluating palonosetron hydrochloride for preventing radiation-induced nausea a…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Golgi Protein for HCC Diagnosis
The trial evaluated a Golgi protein as a diagnostic tool for screening hepatocellular carcinoma and has completed.